A Taxpayer-Funded Clinical Trials Registry and Results Database

摘要

Over the past several years, there has been growing concern about selective publication of clinical trial results [1,2]. The debate has intensified since New York State Attorney General Elliot Spitzer filed suit against GlaxoSmithKline on June 2, 2004, alleging that the company was hiding data regarding the efficacy and safety of selective serotonin reuptake inhibitors in pediatric patients with depression [3].